All Perspectives

Partner D. Reed Freeman was quoted on how the massive amount of data artificial intelligence (AI) models need is potentially undermining one of privacy advocates’ key goals: data minimization.

Health Care Partner David Greenberg will present in a BARBRI CLE course titled “Overpayment Recoveries by Health Insurers: Bringing and Defending Claims, Evaluating Merits, Scope of Recovery” on October 1, 2025.

On September 29, the Bureau of Industry and Security (BIS) issued an interim final rule that significantly expands end user controls under the Export Administration Regulations (EAR) by extending restrictions to foreign entities owned, directly or indirectly, 50% or more by one or more parties on specified lists of proscribed companies, including the Entity List.

On September 19, President Trump signed a Proclamation imposing an additional $100,000 fee on the US entry of certain H-1B employees, effective September 21.

A significant Patent Trial and Appeal Board (PTAB) decision authored by the US Patent and Trademark Office (USPTO) leadership, including the new USPTO Director John A. Squires, signals the importance of artificial intelligence (AI) innovations to the US economy and paves the way for patenting of AI and machine learning (ML) technologies.

Consumer Products Industry Group co-leader, Lynn R. Fiorentino, presented at the 2025 American Conference Institute (ACI) Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products West Coast Edition.

Join International Trade & Investment Associate James Kim and Director of North American Manufacturing Birgit Matthiesen at the Canadian Transportation Equipment Association (CTEA)’s Annual Manufacturers’ Conference 2025.

Earlier this month, the US Department of Health and Human Services (HHS) and US Food and Drug Administration (FDA) announced a nationwide crackdown on direct-to-consumer (DTC) drug advertisements.

The plaintiff, John Snyder, worked for a life insurance company from December 2006 to August 2016.

Headlines that Matter for Companies and Executives in Regulated Industries

More than two years after the Integrity, Notification, and Fairness in Online Retail Marketplaces (INFORM) for Consumers Act took effect on June 27, 2023, the United States, on behalf of the Federal Trade Commission (FTC), brought the first enforcement action under the Act.

As the federal funding deadline of September 30, 2025, approaches, this alert highlights four possible scenarios and their potential implications.

Last month, the US Food and Drug Administration (FDA) announced that it would begin daily publication of adverse event data for drugs and biologics via the FDA Adverse Event Reporting System (FAERS).

On September 8, the US Department of Justice (DOJ) announced the withdrawal of dozens of pending rulemaking actions, including two related to the cannabis industry.

Prop 65 Counsel: What To Know

Following nearly two years of litigation, Cigna Health and Life Insurance Company and the named plaintiffs in Hecht v. Cigna Health and Life Insurance Co., Case No. 1:24-cv-05926 (N.D. Ill.) have announced a class action settlement in principle.

ArentFox Schiff is pleased to announce the addition of partner Lauren Wolven to its growing Private Clients, Trusts & Estates practice in the firm’s Chicago office. Lauren brings over two and a half decades of experience in estate, tax, and succession planning. Her clients include high-net-worth individuals, corporate fiduciaries, and middle market business owners.

FDA Practice Leader and Agriculture & AgTech Industry Leader Karen Carr will participate in a panel at the 2025 CERSA Genome-Edited Microbial Workshop.

On September 15, US Customs and Border Protection (CBP) updated its guidance to implement President Trump’s September 4 Executive Order (EO) laying out terms of the US-Japan trade agreement and the phased reduction of selected US tariffs on Japanese goods.

Investigations Partners Hillary Stemple and Nadia Patel will host a CLE webinar on how health care organizations’ compliance officers and general counsel can bolster compliance mechanisms in light of the re-launch of the Department of Justice and Department of Health and Human Services’ False Claims Act (FCA) Working Group.

On September 12, the US Food and Drug Administration (FDA) released guidance detailing its approach to using alternative tools, such as remote regulatory assessments (RRAs), information sharing with foreign regulators, and virtual inspections, to evaluate drug manufacturing facilities identified in pending marketing applications.

Gayland Hethcoat was featured in a Law360 Healthcare Authority Q&A on how the One Big Beautiful Bill Act (OBBBA) legislation is expected to significantly reduce state-directed payments in Medicaid managed care programs and impact hospitals, nursing facilities, and patients.

In episode three of “Tax Stuff You Should Know,” hosts Bob Pluth and Gene Magidenko delve into the intricate world of S corporations, tracing their historical development, examining the qualifications for electing S status, and identifying the missteps that can inadvertently revoke that designation.

Headlines that Matter for Companies and Executives in Regulated Industries

A proposed settlement in a Pennsylvania case and a citizen suit letter in South Carolina signal that discharging plastic into rivers and streams may trigger liability under the Clean Water Act (CWA) and Resource Conservation and Recovery Act (RCRA). Manufacturers who use plastics in their products or processes should evaluate if any plastic releases exceed their current permit conditions.